# Lewis Killin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lewis-killin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 599 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 7 |
| i10-index | 7 |
| Last Known Institution | Synapse (Spain) |
| OpenAlex ID | https://openalex.org/A5056209087 |
| Works | 19 |

## Researcher papers

- [Environmental risk factors for dementia: a systematic review](https://scholariq.org/papers/environmental-risk-factors-for-dementia-a-systematic-review/)
- [Aluminium and fluoride in drinking water in relation to later dementia risk](https://scholariq.org/papers/aluminium-and-fluoride-in-drinking-water-in-relation-to-later-dementia-risk/)
- [Digital Support Platform: a qualitative research study investigating the feasibility of an internet-based, postdiagnostic support platform for families living with dementia](https://scholariq.org/papers/digital-support-platform-a-qualitative-research-study-investigating-the/)
- [The effect of age on the FCSRT-IR and temporary visual memory binding](https://scholariq.org/papers/the-effect-of-age-on-the-fcsrt-ir-and-temporary-visual-memory-binding/)
- [Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model](https://scholariq.org/papers/data-sharing-in-neurodegenerative-disease-research-challenges-and-learnings-from/)
- [The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis](https://scholariq.org/papers/the-effect-of-funding-sources-on-donepezil-randomised-controlled-trial-outcome-a/)
- [Motivating and constraining factors for research participation in Scottish care homes](https://scholariq.org/papers/motivating-and-constraining-factors-for-research-participation-in-scottish-care/)
- [The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks](https://scholariq.org/papers/the-innovative-medicines-initiative-neurodegeneration-portfolio-from-individual/)
- [Seeing through the double blind](https://scholariq.org/papers/seeing-through-the-double-blind/)
- [Participating in innovative medicines initiative funded neurodegenerative disorder projects—An impact analysis conducted as part of the NEURONET project](https://scholariq.org/papers/participating-in-innovative-medicines-initiative-funded-neurodegenerative/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Health and Medical Research Impacts](https://scholariq.org/topics/health-and-medical-research-impacts/)
- [Geriatric Care and Nursing Homes](https://scholariq.org/topics/geriatric-care-and-nursing-homes/)

## Researcher university

- [Synapse (Spain)](https://scholariq.org/institutions/synapse-spain/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.